Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
B3GALT4	"beta3Gal-T4, GalT4"	ENSG00000235863	"Beta-1,3-galactosyltransferase 4"	O96024	6	33277132-33284832	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;SCLC-21H: 3.2;SK-BR-3: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043001	Approved					NA	NA					"HPA043001: AB_2678265"	"unprognostic (3.71e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.75e-2)"	7.0	6.9	3.0	9.8	4.0	3.0	6.7	5.3	6.3	7.6	9.0	6.2	13.1	8.0	6.2	7.0	14.0	6.1	9.4	5.7	3.6	3.4	7.1	1.7	6.7	11.9	3.7	3.0	3.1	3.1	5.3	4.4	7.4	4.0	6.5	4.9	6.7	9.1	15.9	2.7	10.9	12.5	4.3	4.6	11.1	7.7	19.0	2.5	14.7	5.6	5.3	9.8	8.6	7.9	7.3	4.1	12.4	8.4	6.3	9.5	5.2	0.0	0.3	0.6	0.2	0.9	1.6	0.8	0.3	0.4	0.0	0.1	0.0	5.1	0.0	0.0	0.7	1.2	2.6	0.0	0.2	0.0	2.8	0.3	0.9	0.4	0.0	1.0	0.0	2.7	2.1	1.3	0.1	0.1	0.0	0.7	2.4	0.0	0.3	0.0	0.1	1.3	1.2	0.2	1.9	0.3	0.2	0.0	0.0	0.0	0.8	3.2	0.4	0.1	5.2	0.4	0.6	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.7	12.4	6.9	10.0	9.5	6.7	7.4	6.0	5.9	8.0	4.1	7.3	5.7	5.1	7.3	6.3	8.4	3.3	6.3	5.2	3.0	4.0	5.3	6.3	3.6	3.4	3.7	3.0	4.0	2.5	11.9	4.5	10.4	5.9	2.9	13.7	3.3	17.8	14.7	7.9	14.0	3.9	15.4	5.0	12.9	25.9	9.8	29.5	0.0	16.5	9.9	5.2	9.6	10.3	0.5	18.3	11.1	12.1	11.1	23.0	54.2	7.2	12.7	8.5	30.7	15.3	11.8	14.7	25.9	5.6	5.3	13.9	6.5	3.8	28.9	3.0	4.3	26.8	14.9	10.1	14.6
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623410-57633355	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.4"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 8.1;Horizontal cells: 20.6;Sertoli cells: 6.5;Smooth muscle cells: 6.6"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 22.0;HDLM-2: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	NA	NA		9500			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	3.0	2.1	12.9	2.3	16.4	1.0	1.5	26.5	32.4	1.9	2.4	1.0	0.0	1.4	2.2	3.8	1.3	1.4	1.5	3.9	15.3	11.2	1.3	1.3	1.7	1.6	6.5	14.3	1.0	1.2	1.1	1.0	1.3	11.6	4.2	2.2	1.6	3.2	6.8	8.1	1.6	1.9	3.2	2.3	1.3	1.4	1.6	2.3	0.0	1.3	0.6	1.8	1.5	0.9	0.0	0.0	0.0	0.0	0.8	1.9	0.0	2.8	14.7	3.2	5.7	0.2	0.0	0.0	1.4	3.0	6.0	6.4	0.9	7.7	0.8	22.0	4.1	13.6	1.4	2.5	1.1	2.0	18.7	0.9	0.2	3.7	4.8	0.2	0.7	1.4	0.0	0.4	3.6	0.2	2.4	0.1	3.3	2.3	4.6	1.0	3.8	0.6	0.0	3.8	0.3	2.9	0.0	4.4	2.3	0.0	0.0	12.3	3.1	0.8	0.4	0.1	0.2	2.7	1.0	0.0	3.6	8.3	6.9	9.1	11.5	8.6	0.8	8.1	0.9	9.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	12.9	16.4	26.5	25.9	15.3	11.2	6.5	14.3	11.6	2.3	0.0	0.0	0.0	0.0	0.3	8.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.2	0.2	1.1	0.1	0.0	0.0	0.1	20.6	0.0	0.0	0.0	0.4	2.6	0.0	3.3	4.6	0.0	0.8	0.6	0.0	2.8	0.0	1.9	6.5	6.6	0.3	0.9	0.0	0.0	0.0	0.0	0.1
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574587	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 38.2;Enterocytes: 17.4;Muller glia cells: 29.4;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 22.7;CACO-2: 6.3;EFO-21: 12.3;K-562: 5.3;OE19: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001220, HPA077138"	Approved		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Vesicles	Nucleoplasm	"HPA001220: AB_1078933, HPA077138: "	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	0.8	0.6	8.4	0.7	9.6	1.2	0.8	1.4	12.3	1.4	11.3	25.8	0.0	24.2	1.3	2.3	0.8	2.2	13.4	0.5	12.1	8.3	13.3	1.6	1.5	0.9	14.0	2.6	1.2	2.9	0.6	0.5	1.3	12.4	1.2	2.8	0.3	1.0	1.9	1.9	2.1	25.1	0.7	28.7	0.7	7.2	2.5	7.8	0.0	0.6	0.0	0.4	1.0	0.7	2.3	2.8	2.3	0.7	0.3	0.8	0.0	0.1	22.7	0.4	0.2	0.0	0.0	1.7	0.0	0.1	0.0	0.0	6.3	3.1	0.3	12.3	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.8	0.3	0.2	4.1	0.5	0.1	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.3	5.3	0.6	0.0	0.1	0.3	0.9	3.3	8.5	0.3	0.2	0.1	0.6	0.9	0.1	0.3	1.5	0.0	0.4	0.2	0.6	0.1	0.1	0.6	0.2	0.1	0.2	0.0	2.0	1.2	0.3	0.1	0.1	0.2	0.9	0.7	0.1	0.4	0.5	0.7	1.8	0.7	0.8	0.2	2.3	0.5	0.8	2.3	0.3	0.3	2.8	0.1	0.0	8.4	9.6	1.4	10.3	12.1	8.3	14.0	2.6	12.4	7.8	0.0	0.0	0.0	0.1	0.3	0.7	0.6	38.2	0.0	0.0	3.5	0.0	0.0	13.3	5.6	0.9	0.1	17.4	0.0	9.7	0.0	0.0	0.2	0.0	1.3	0.1	0.0	10.5	0.0	0.8	0.6	1.4	0.0	0.0	0.0	7.4	29.4	4.6	7.0	2.1	18.9	1.1	0.0	0.0	3.1	7.5	0.3	0.2	0.0	8.0	0.0
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.8	10.0	6.5	7.7	39.9	20.7	139.7	9.3	25.2	12.0	15.4	14.2	13.8	2.8	8.3	19.0	8.9	5.6	6.1	11.9	8.9	16.3	5.1	11.2	6.0	7.3	20.5	7.7	11.4	23.9	11.4	10.8	6.4	23.6	18.4	3.9	10.1	10.9	13.1	6.8	4.6	5.1	4.4	12.2	4.4	4.0	4.3	13.2	12.9	8.5	2.0	6.8	12.0	19.4	11.7	12.0	12.9	20.4	10.7	7.7	5.4	10.5	7.9	8.6	13.7	0.9	16.2	11.2	5.8	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0	17.9	22.3	15.9	10.2	5.4	11.3	7.1	35.7	14.7	17.0	26.2	5.9	80.5	23.2	42.1	22.3	10.5	31.5	0.0	31.3	47.6	24.4	11.4	26.5	36.5	70.6	4.8	16.3	18.4	38.2	3.1	14.1	38.3	13.5	81.2	22.4	20.0	27.0	39.5	19.8	24.2	15.0	12.9	10.8	1.1	7.2	3.0	41.1	20.0	28.4	8.4
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236606-219245478	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA					"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	6.9	5.4	2.7	2.0	3.7	2.3	5.6	1.6	3.3	4.0	5.8	4.6	4.5	1.6	5.3	7.9	2.5	14.3	8.6	3.4	3.1	3.5	18.5	3.5	4.1	2.5	2.1	2.1	6.1	3.1	11.7	6.7	7.4	5.6	4.5	2.0	13.2	5.8	3.0	1.4	2.5	4.4	3.4	2.3	3.9	2.1	57.0	1.4	3.1	5.0	1.4	2.4	4.0	2.0	1.7	2.8	3.2	8.9	1.4	1.8	2.2	2.4	4.3	6.7	5.4	7.4	9.1	3.4	4.1	8.7	5.2	4.9	1.6	6.9	0.8	3.7	3.6	3.9	1.3	1.9	4.0	4.1	2.2	3.3	2.5	6.2	3.9	18.3	0.9	4.0	10.8	2.5	4.9	3.0	12.3	4.6	3.8	1.5	4.8	4.8	3.5	2.1	2.5	1.1	0.9	1.2	2.2	3.7	3.4	10.5	1.4	4.3	3.9	3.4	4.8	4.0	4.7	7.5	2.2	3.6	4.4	5.3	2.5	2.2	4.6	1.3	1.3	8.1	1.1	11.0	2.0	7.0	0.5	1.1	8.9	0.6	0.6	0.9	1.1	2.8	1.7	1.8	1.3	3.2	1.4	6.7	1.2	0.3	2.2	2.7	3.7	1.6	3.3	3.1	3.5	2.1	2.1	5.6	1.4	3.0	3.2	0.8	2.5	1.5	4.8	1.7	2.5	24.1	7.9	3.5	11.8	2.9	3.3	3.1	21.1	2.5	2.1	0.0	1.6	1.5	4.4	2.7	0.0	1.0	11.7	3.2	4.7	9.8	6.1	17.2	10.0	4.5	8.5	1.0	2.8	3.5	1.7	2.3	6.0	15.3	9.5	6.5	1.2	80.3	5.4	1.5	1.1	2.1	1.7	1.6
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340919-72376476	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	30.1	37.4	23.1	18.0	22.9	35.5	37.8	23.3	28.1	30.6	20.5	19.4	30.1	18.5	25.9	65.7	11.7	21.8	29.2	33.8	23.4	12.8	34.6	29.5	43.9	31.4	24.9	21.1	20.9	22.2	18.1	22.9	37.9	18.8	18.1	26.0	26.9	24.8	22.0	17.7	17.9	24.6	23.4	21.4	31.5	22.6	18.0	22.9	12.1	31.2	11.1	16.4	26.7	17.1	16.1	37.9	22.4	32.7	17.8	18.1	21.3	7.5	12.8	5.5	10.6	45.5	51.9	7.9	10.6	53.8	23.0	36.8	6.7	55.4	6.3	10.2	21.3	12.0	15.1	14.6	6.7	14.6	5.1	5.8	7.9	12.7	11.6	35.2	18.9	22.7	44.1	20.2	10.0	17.9	42.2	21.0	9.4	12.2	39.2	30.6	6.5	4.1	9.5	3.1	24.7	0.1	4.2	12.0	14.2	25.7	11.9	4.8	5.3	26.5	25.1	59.9	11.7	4.6	23.9	10.6	34.5	14.4	31.7	11.2	20.9	28.2	6.5	12.5	25.3	16.7	8.9	32.7	22.4	18.1	13.7	15.8	16.1	12.0	15.8	37.9	15.6	9.5	14.0	3.1	17.8	4.8	14.4	10.7	21.3	23.1	22.9	23.3	28.1	23.4	12.8	24.9	21.1	18.8	22.9	59.6	55.5	41.1	30.3	19.7	40.2	22.6	35.7	17.4	28.4	62.8	100.1	116.3	51.4	65.3	16.3	43.0	46.2	0.0	33.3	55.3	62.5	30.5	29.9	37.8	207.1	25.4	45.3	44.2	76.0	10.5	68.7	108.5	89.4	50.5	39.4	48.4	43.8	84.5	42.1	55.5	56.1	45.3	20.6	20.4	28.2	13.7	131.8	47.5	44.4	25.0
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 174.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 395.6;Hofbauer cells: 319.1;Syncytiotrophoblasts: 412.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 108.4;GAMG: 90.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		43000000			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	48.0	21.9	7.7	13.6	11.6	11.1	26.1	7.4	11.2	25.8	34.2	9.5	18.0	21.6	22.1	77.3	20.6	17.3	28.1	46.3	7.1	9.1	30.4	44.5	40.9	19.3	8.5	6.7	22.7	30.4	21.8	14.3	174.3	9.3	22.6	26.3	21.0	34.6	13.3	21.0	15.3	33.6	21.0	8.7	20.5	20.7	16.2	6.1	10.8	33.7	15.2	15.4	24.0	19.7	8.9	59.8	23.8	65.9	7.6	16.4	42.9	20.3	16.0	5.6	18.5	108.4	33.5	18.2	25.0	81.1	24.4	53.0	18.8	26.6	0.0	19.8	20.5	90.2	16.4	6.0	25.4	32.3	11.4	10.8	2.6	15.5	14.1	31.8	2.2	22.0	29.5	15.0	25.6	17.2	38.5	27.9	6.4	7.5	33.3	26.7	20.6	2.6	5.1	5.2	19.3	7.2	6.2	8.1	26.5	16.8	18.6	3.6	4.5	19.4	13.2	24.1	10.1	13.9	15.1	16.6	16.1	4.0	29.6	23.0	15.4	26.5	0.1	36.7	20.0	29.2	14.5	65.9	18.6	14.2	24.5	16.4	8.9	11.7	13.1	59.8	5.5	11.2	10.9	23.8	7.6	14.6	18.0	13.7	42.9	7.7	11.6	7.4	11.2	7.1	9.1	8.5	6.7	9.3	6.1	38.7	35.5	39.5	70.4	39.0	9.5	18.9	63.7	20.1	18.2	27.9	7.9	395.6	16.6	123.0	1.1	60.6	71.9	0.0	111.0	143.1	100.1	65.8	69.2	62.8	319.1	9.5	21.9	83.4	134.6	1.7	78.9	151.2	69.2	83.8	50.0	34.8	68.2	51.8	67.8	65.5	10.6	45.3	54.5	0.2	1.1	28.4	412.8	37.3	76.2	54.8
HEXDC	FLJ23825	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 30.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.52e-5)"	12.7	8.5	7.1	16.6	9.3	14.3	8.7	13.2	7.3	10.1	7.6	8.8	12.8	8.0	10.0	11.1	7.9	10.3	9.4	5.7	7.2	4.6	9.9	11.6	12.4	11.6	12.8	5.5	13.6	72.9	10.2	14.6	5.7	7.4	14.1	4.2	7.0	13.3	9.2	20.4	11.3	12.3	6.0	6.1	15.6	8.8	4.7	11.4	8.6	11.7	8.6	10.7	8.3	8.8	5.9	30.3	3.3	11.5	11.9	9.8	4.4	3.0	7.7	3.4	5.3	10.4	9.0	10.5	3.9	4.8	4.1	4.7	2.7	10.4	8.1	4.3	1.6	2.8	4.3	2.0	2.3	1.9	5.6	13.1	3.6	6.8	4.5	9.3	2.4	9.3	6.4	2.3	1.1	4.2	5.6	5.3	6.2	4.6	2.8	1.1	7.0	8.4	9.0	3.1	5.6	4.7	10.0	2.9	15.8	3.1	4.6	4.8	10.2	8.1	5.3	7.3	1.6	8.5	9.2	5.3	2.7	5.1	2.0	2.7	12.7	2.4	6.0	2.1	6.9	2.7	3.3	1.7	2.7	9.8	11.5	6.5	4.6	2.2	3.4	2.0	5.9	3.5	5.1	3.0	11.9	4.9	30.3	1.4	4.4	7.1	9.3	13.2	7.3	7.2	4.6	12.8	5.5	7.4	11.4	3.0	8.5	8.3	9.5	4.1	19.2	4.4	12.7	9.4	12.5	17.4	17.7	4.7	8.3	5.4	1.2	8.0	16.8	0.0	8.2	5.3	6.2	10.5	10.3	12.9	13.7	39.7	13.3	16.0	9.5	2.1	33.1	11.5	5.0	16.2	14.4	18.7	5.8	10.1	23.3	6.1	29.0	19.4	6.2	6.0	10.2	2.0	3.3	12.9	12.0	7.5
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	4	"JURKAT: 3.6;MOLT-4: 6.9;RPMI-8226: 13.7"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"											NA	NA						"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.7	0.0	0.0	6.9	1.1	0.0	0.0	0.0	1.6	0.0	13.7	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.4	2.4	2.4	5.6	8.2	3.1	4.8	2.2	7.5	6.5	9.6	14.1	2.6	0.8	5.7	2.9	38.4	1.3	5.1	2.0	2.5	2.0	3.4	1.2	1.4	16.5	14.7	1.5	6.9	5.1	3.8	7.9	4.1	3.9	5.8	1.6	2.6	5.8	3.3	4.3	1.2	2.3	1.9	4.3	1.9	1.7	1.3	8.5	10.8	5.2	1.8	1.1	2.4	3.3	5.8	3.2	6.2	7.1	2.4	4.3	2.5	6.0	3.9	7.2	11.5	1.7	3.1	3.9	3.0	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0	23.8	47.7	44.6	42.4	30.5	24.5	18.7	38.2	10.7	17.0	45.4	23.6	52.4	8.3	82.1	0.8	27.6	80.5	0.0	51.5	49.0	63.2	112.7	66.9	21.3	139.8	9.5	108.9	26.4	42.3	0.7	25.6	53.4	67.4	25.2	37.4	48.4	45.4	80.7	21.9	55.3	29.8	25.8	42.2	5.0	7.5	36.4	164.8	28.7	38.6	31.8
NEU2	SIAL2	ENSG00000115488	"Neuraminidase 2"	Q9Y3R4	2	233032672-233035057	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"skin 1: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 1.1;BEWO: 1.6;PC-3: 3.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.2;hippocampal formation: 1.1"	CAB022336	Uncertain					NA	NA		9000			"CAB022336: "						"unprognostic (1.30e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988134-75018893	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 58.9;Spermatocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	5.4	13.4	3.7	10.5	6.9	17.0	5.4	7.9	9.1	4.0	3.9	3.0	4.1	3.6	5.4	4.8	3.9	4.4	3.6	5.9	4.0	4.5	4.3	6.7	8.7	9.0	3.8	6.6	7.2	7.3	15.1	11.2	3.1	4.2	9.7	5.4	5.6	4.8	4.6	19.1	6.7	4.7	4.0	3.5	5.5	5.1	44.6	3.0	19.0	6.8	3.5	7.5	4.5	3.1	3.2	3.8	5.8	6.4	1.2	4.2	2.2	4.6	4.0	3.4	6.6	2.6	2.5	3.8	4.5	2.9	5.2	4.0	13.7	3.9	13.3	4.6	3.6	6.6	4.3	8.2	5.8	7.9	7.0	4.4	10.9	7.4	5.6	2.9	17.2	10.6	3.0	4.9	5.2	8.1	3.4	3.7	19.0	17.7	10.0	5.9	5.0	16.9	8.9	4.2	9.1	5.4	14.8	9.0	11.7	6.4	4.9	6.3	4.0	6.9	4.6	20.2	4.2	9.8	4.4	5.6	6.5	6.5	4.3	4.5	8.2	8.0	26.6	1.9	8.9	5.5	2.1	6.4	5.8	4.1	3.7	3.0	2.8	3.2	3.9	3.8	3.2	3.5	4.2	3.3	1.2	4.6	2.7	2.3	2.2	3.7	6.9	7.9	9.1	4.0	4.5	3.8	6.6	4.2	3.0	3.0	5.8	2.2	1.8	0.5	7.2	7.3	2.5	2.7	4.5	1.8	58.9	1.8	0.0	1.0	5.7	1.6	1.3	0.0	2.6	1.2	1.5	2.7	1.1	7.2	4.8	11.1	6.9	4.3	8.6	5.3	1.4	4.5	0.0	4.6	2.9	2.9	2.7	0.0	1.8	3.3	5.8	0.0	2.2	32.5	1.7	0.5	1.1	3.5	3.2	0.4
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241808825-241817413	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 27.1;liver: 42.9"	"Cell type enhanced"	"Detected in some"	14	"Enterocytes: 65.6;Hepatocytes: 117.5;Intestinal endocrine cells: 33.1;Mucus-secreting cells: 40.3;Paneth cells: 66.2;Undifferentiated cells: 40.1"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"Hep G2: 22.5;HMC-1: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037394	Enhanced					NA	NA					"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.6	0.5	6.5	0.7	5.3	5.7	0.3	1.9	7.0	0.6	13.9	4.9	0.0	9.3	0.3	0.3	0.7	1.1	2.6	0.6	6.4	5.8	1.4	42.9	0.4	0.5	6.9	4.4	0.4	0.3	0.3	0.4	0.4	3.8	0.5	6.1	0.0	0.4	0.4	3.6	0.3	27.1	0.4	4.1	0.5	0.5	0.6	2.3	0.0	0.4	2.8	0.3	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.5	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	5.3	1.9	4.0	6.4	5.8	6.9	4.4	3.8	2.3	0.0	0.0	0.9	0.0	0.0	0.7	0.5	0.0	0.0	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.0	65.6	0.0	0.0	0.0	0.2	0.0	1.1	117.5	1.2	0.0	33.1	0.6	3.2	0.0	0.6	0.7	0.0	0.0	40.3	26.2	0.0	66.2	0.7	8.6	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	40.1	0.1
ST3GAL1	"SIAT4A, SIATFL, ST3GalA.1, ST3O"	ENSG00000008513	"ST3 beta-galactoside alpha-2,3-sialyltransferase 1"	Q11201	8	133454848-133571940	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 143.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 47.7;RT4: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040466	Approved				"Intracellular and membrane"	NA	NA		290000			"HPA040466: AB_10805712"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.83e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.95e-2)"	14.4	14.4	5.1	11.8	3.6	10.2	7.8	3.7	6.5	9.8	5.4	4.1	18.1	1.8	8.5	11.8	9.0	9.0	17.0	35.4	4.2	3.4	23.1	44.5	11.9	12.4	4.7	2.5	10.3	8.2	4.4	7.6	49.8	6.4	7.1	2.9	11.2	18.2	15.1	20.9	4.0	6.5	12.3	3.9	17.3	9.4	5.0	1.4	6.3	40.2	7.9	16.8	14.0	14.3	22.7	7.0	21.3	9.8	21.9	19.9	9.5	4.7	2.5	1.0	2.9	10.3	5.4	5.3	5.4	13.1	2.1	1.6	4.4	5.3	1.1	3.7	9.9	1.0	1.4	3.4	4.0	1.9	13.3	0.6	9.9	7.6	8.8	7.9	2.0	7.9	6.3	2.0	7.5	4.2	9.7	9.2	2.6	0.1	15.3	1.5	5.0	2.8	2.7	0.7	25.6	47.7	3.3	1.3	8.1	0.9	36.7	0.2	0.8	2.4	8.2	2.5	5.8	1.5	2.7	8.9	6.5	10.3	5.6	2.3	18.9	13.6	1.2	14.7	6.9	6.6	20.5	4.7	21.3	14.4	4.5	13.3	12.8	14.6	16.4	2.9	22.7	19.9	18.5	8.6	21.9	9.8	7.0	8.9	9.5	5.1	3.6	3.7	6.5	4.2	3.4	4.7	2.5	6.4	1.4	6.0	58.6	36.0	6.4	5.0	7.4	59.9	12.7	8.1	21.6	1.8	2.0	8.2	5.0	34.3	2.8	41.9	0.0	23.3	21.6	34.2	37.0	10.6	8.1	143.6	32.3	57.2	0.0	33.7	44.5	0.9	33.9	42.2	13.5	78.5	0.4	10.1	25.8	0.0	67.5	39.3	21.7	12.9	32.2	0.2	1.9	3.0	22.1	43.7	0.0	37.3
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375978-70439237	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	12.6	9.1	9.3	17.2	11.9	14.3	8.9	24.1	10.6	11.3	8.8	5.1	9.3	9.2	13.9	5.6	5.8	9.0	6.8	9.2	10.4	6.0	8.8	12.9	9.3	14.9	5.1	4.7	13.6	4.2	8.8	7.2	8.8	6.8	7.5	4.7	9.9	4.9	9.0	33.3	6.0	10.5	12.0	4.0	17.7	5.4	9.6	5.9	16.0	6.6	4.9	12.6	9.1	12.0	3.2	14.3	11.2	2.2	2.8	4.2	1.1	1.4	8.5	7.4	9.8	4.0	5.4	1.7	6.0	6.4	6.7	3.3	5.1	3.3	4.1	10.8	6.5	6.0	1.0	2.9	2.5	3.2	9.7	4.7	17.5	3.5	7.6	4.9	6.4	28.9	4.1	1.4	6.8	1.2	8.2	9.2	7.1	23.9	4.0	3.7	0.7	6.7	17.5	10.0	2.8	4.6	12.9	2.8	5.5	4.5	1.1	3.3	9.7	15.1	0.3	6.6	8.0	1.6	7.1	9.8	8.5	10.2	3.6	4.4	8.4	3.3	8.4	9.3	5.4	11.9	2.7	2.0	5.7	2.0	2.2	1.9	1.7	2.4	2.2	1.0	3.2	4.2	3.3	11.2	2.8	1.3	14.3	2.7	1.1	9.3	11.9	24.1	10.6	10.4	6.0	5.1	4.7	6.8	5.9	8.9	6.9	13.0	3.6	3.0	15.1	5.6	10.2	1.4	2.3	8.7	13.7	3.7	0.0	5.4	14.0	13.1	5.1	46.7	3.8	1.6	10.6	2.2	17.3	11.5	11.6	17.5	12.7	14.7	10.0	25.8	10.9	14.4	1.7	23.4	4.0	5.1	2.4	0.0	7.8	5.0	10.2	6.5	7.1	5.4	8.1	2.0	1.5	8.6	5.2	1.8
ST3GAL4	"CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ"	ENSG00000110080	"ST3 beta-galactoside alpha-2,3-sialyltransferase 4"	Q11206	11	126355640-126440344	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 74.2"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 804.9"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 29.6;granulocytes: 31.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 45.3;WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049827	Approved				"Intracellular and membrane"	NA	NA					"HPA049827: AB_2680900"	"unprognostic (8.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.90e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.78e-3)"	7.8	38.0	6.2	6.5	12.2	7.8	12.9	4.0	13.6	8.3	27.0	26.4	5.1	2.0	6.0	42.1	25.5	6.0	11.4	26.5	8.6	6.2	16.7	11.5	12.4	9.0	18.7	9.0	39.3	5.1	0.8	5.6	74.2	13.8	12.1	31.5	35.7	14.4	8.0	1.9	5.6	3.8	11.0	23.0	17.0	4.8	18.8	12.4	2.2	6.1	4.3	10.1	21.1	13.2	0.1	29.6	31.3	2.6	1.2	1.7	1.8	4.9	4.1	3.2	2.7	9.5	7.9	8.0	5.7	11.1	5.2	3.6	2.4	8.5	1.4	4.3	9.0	17.7	7.7	6.7	3.7	4.1	5.3	1.9	12.6	10.2	2.7	6.2	15.0	25.8	6.3	6.0	7.8	12.4	9.6	6.9	5.5	7.8	3.8	6.4	20.2	4.7	15.4	2.0	31.9	26.8	4.9	9.9	0.6	1.2	14.2	6.1	3.9	6.3	38.2	45.3	2.2	13.3	10.0	2.5	12.5	2.8	8.8	10.7	0.3	0.8	0.7	5.7	23.0	102.8	31.3	1.6	0.2	1.7	2.6	1.6	0.1	0.6	1.1	6.6	0.0	0.1	0.8	22.8	1.2	1.2	29.6	0.0	1.8	6.2	12.2	4.0	13.6	8.6	6.2	18.7	9.0	13.8	12.4	8.9	1.1	3.7	5.3	9.4	4.2	26.6	7.6	1.4	4.5	29.6	9.8	90.3	41.4	4.3	1.1	9.8	34.8	0.0	5.6	59.0	44.0	13.8	41.5	8.9	16.2	4.8	5.1	36.8	4.1	3.8	70.5	7.2	74.2	10.8	43.5	5.0	7.3	93.0	88.1	3.4	8.3	12.9	23.6	1.4	3.8	5.8	804.9	12.2	8.8	13.1
ST3GAL5	"SIAT9, SIATGM3S, ST3GalV"	ENSG00000115525	"ST3 beta-galactoside alpha-2,3-sialyltransferase 5"	Q9UNP4	2	85837120-85905199	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.1"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 80.4;Alveolar cells type 2: 105.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 41.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.2;RT4: 22.2;SK-MEL-30: 18.4;U-266/84: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034708, HPA040425, HPA068928"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060"	"unprognostic (7.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.25e-7)"	"unprognostic (2.22e-1)"	"unprognostic (5.74e-2)"	"prognostic favorable (4.99e-4)"	"prognostic favorable (4.48e-4)"	8.0	40.1	15.3	7.2	18.5	4.1	4.2	9.9	34.9	3.3	3.8	18.8	0.0	2.7	8.0	2.9	2.9	4.9	11.8	2.1	14.8	12.0	2.4	7.0	18.0	11.5	14.0	13.4	7.2	2.9	1.5	7.4	24.1	18.1	4.8	5.0	18.7	4.8	2.2	9.5	5.0	3.4	6.2	18.0	11.1	4.1	9.0	13.4	5.5	36.7	0.4	6.9	30.9	7.8	2.5	1.1	1.3	6.1	1.4	1.8	0.5	0.1	12.8	1.2	26.2	10.9	5.9	3.9	2.8	8.6	2.7	2.4	0.2	9.3	0.3	0.1	4.8	1.2	0.5	1.7	3.0	3.4	0.1	1.5	0.2	0.5	0.4	8.7	0.1	3.8	3.3	0.4	1.0	0.4	4.9	6.5	3.5	0.3	14.5	8.8	0.8	0.8	1.4	0.1	4.4	0.0	1.6	8.3	5.1	1.4	22.2	1.8	1.8	0.1	0.0	18.4	2.7	0.1	0.5	2.1	0.0	1.3	0.0	0.2	14.6	19.3	0.2	2.1	2.6	13.2	0.9	1.8	0.1	1.4	6.1	1.8	2.5	0.8	0.9	1.1	1.5	0.7	0.8	1.3	1.4	5.1	0.4	0.3	0.5	15.3	18.5	9.9	21.9	14.8	12.0	14.0	13.4	18.1	13.4	80.4	105.8	40.9	24.7	4.9	49.5	1.6	30.6	14.7	50.0	3.5	55.0	0.3	3.3	8.1	9.5	5.2	0.0	0.0	14.5	0.5	10.3	8.0	33.5	15.5	30.3	68.3	6.4	33.2	46.9	8.7	7.5	25.6	30.4	12.6	0.0	52.2	6.7	0.0	1.8	2.9	41.0	0.0	5.0	6.9	20.0	3.3	0.2	19.7	0.0	5.1
ST6GALNAC2	"SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM"	ENSG00000070731	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2"	Q9UJ37	17	76565379-76586956	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 78.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 447.7;Late spermatids: 1248.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 19.2"	"Cell type enriched"	"Detected in some"	9	"neutrophil: 23.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 23.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.6;HaCaT: 11.8;HBEC3-KT: 10.7;hTCEpi: 30.0;MCF7: 11.6;SK-MEL-30: 39.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (8.93e-3)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	4.3	1.7	0.6	2.7	1.8	0.4	7.0	0.4	1.3	8.6	7.2	6.0	3.6	0.4	2.6	8.8	17.2	28.3	2.1	4.6	2.1	1.3	10.6	1.3	11.3	1.7	4.0	1.0	5.0	3.6	1.5	2.1	18.3	19.2	6.7	3.4	78.2	6.6	6.1	11.3	27.3	2.5	4.7	3.7	2.0	3.5	17.1	1.3	0.7	17.7	12.4	6.9	8.3	7.6	0.0	0.2	23.5	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	9.6	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.0	11.8	0.1	10.7	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	30.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	3.2	0.1	0.0	1.3	0.0	39.0	0.6	7.6	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.1	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.5	0.0	0.1	0.0	0.0	0.1	0.6	1.8	0.4	1.3	2.1	1.3	4.0	1.0	19.2	1.3	0.0	1.0	0.5	34.2	29.2	6.0	4.8	5.1	9.4	6.8	0.0	25.5	7.7	0.0	0.1	447.7	3.1	1.3	0.0	0.0	15.3	3.4	4.5	1.1	0.8	2.8	0.0	0.0	9.2	5.6	1248.1	6.9	2.4	62.4	1.0	3.4	71.0	0.1	0.0	6.7	0.3	74.9	19.4	3.1	8.4	4.4	26.5	8.8	2.2	1.5	31.0
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074719-76634601	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	23	"Endothelial cells: 21.6;Ito cells: 57.1;Kupffer cells: 11.7;Muller glia cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.6;HUVEC TERT2: 23.6;SK-MEL-30: 32.2;TIME: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054566: AB_2682526, HPA055399: AB_2682806"	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	20.7	2.9	7.0	3.6	13.0	5.3	13.9	3.8	9.7	4.3	4.0	13.4	2.0	1.8	10.7	2.1	3.8	4.2	4.7	7.8	8.8	6.0	14.9	3.9	7.5	5.1	16.3	3.6	4.7	2.2	12.6	4.3	5.7	12.9	2.5	4.7	2.8	2.3	3.5	3.3	1.9	2.7	8.3	19.0	3.0	3.0	1.2	12.5	0.0	23.2	1.5	1.7	5.5	5.2	5.9	3.0	5.2	8.3	0.4	1.9	2.6	0.1	0.0	18.6	0.0	0.3	0.0	0.0	0.0	2.2	0.3	0.2	6.0	0.0	0.3	1.2	0.1	1.2	0.0	0.0	0.2	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.5	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	1.4	0.0	0.9	0.8	0.0	0.0	0.0	1.4	4.6	0.0	0.0	32.2	4.5	0.0	0.1	10.4	0.1	1.5	0.0	1.7	0.0	0.0	0.0	0.0	4.2	2.8	0.0	8.3	3.7	0.0	2.9	0.0	3.3	0.5	0.8	3.0	5.9	1.9	1.9	5.2	0.4	5.3	0.0	0.0	2.6	7.0	13.0	3.8	9.7	8.8	6.0	16.3	3.6	12.9	12.5	3.0	1.0	1.3	0.1	0.2	3.0	1.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.8	0.0	0.0	57.1	11.7	0.4	0.0	1.5	5.0	0.0	0.3	11.0	0.2	3.2	0.0	0.0	0.5	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.1
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;pancreas: 61.0"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 58.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 58.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.5;RPMI-8226: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	8.0	7.8	5.6	7.9	5.6	26.2	12.1	9.8	8.5	9.2	9.3	4.8	28.9	11.7	8.7	9.6	6.9	8.7	12.2	18.4	5.2	3.4	9.4	5.0	13.5	9.7	4.2	4.7	14.9	61.0	2.4	9.4	4.3	4.8	6.1	5.4	4.8	9.3	30.0	12.6	4.0	9.7	6.1	3.9	18.2	7.2	4.3	4.7	4.7	6.3	5.9	12.5	8.9	8.3	6.7	58.8	0.8	3.2	4.3	3.4	2.4	3.2	5.5	1.4	7.0	9.9	7.6	1.0	5.6	6.2	5.7	3.3	3.1	5.9	20.5	8.5	7.0	8.1	7.9	2.9	5.9	0.9	35.5	2.4	6.5	17.6	11.6	12.1	0.5	6.8	9.2	6.3	5.1	4.6	4.6	15.2	3.9	4.6	13.7	2.7	1.5	1.2	0.7	1.6	10.5	13.6	6.2	3.7	50.3	5.8	0.1	12.0	2.7	8.1	17.6	1.0	0.5	3.6	4.2	10.8	4.7	5.4	14.6	8.7	22.4	11.5	6.4	9.4	2.9	0.6	0.8	2.1	0.0	2.9	1.9	3.3	6.7	1.8	3.4	2.8	4.9	2.3	3.1	0.2	4.3	3.2	58.8	3.3	2.4	5.6	5.6	9.8	8.5	5.2	3.4	4.2	4.7	4.8	4.7	8.9	24.5	43.4	11.9	1.9	2.4	10.3	10.2	5.3	4.5	1.8	0.0	0.9	1.7	14.0	0.1	10.8	19.6	23.3	12.5	14.4	11.9	2.0	8.1	1.5	22.1	0.0	65.1	4.9	11.4	0.0	16.1	8.5	6.8	12.6	13.1	14.1	11.9	6.5	40.3	17.3	1.7	12.9	8.9	0.2	1.3	2.8	3.8	10.2	16.4	10.0
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867441-77065711	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell type enriched"	"Detected in some"	7	"Alveolar cells type 1: 50.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Group enriched"	"Detected in many"	4	"amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA065593: AB_2685515, HPA070354: AB_2686260"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.7	10.1	22.1	5.2	22.3	0.4	4.2	0.6	12.7	2.9	3.4	0.3	0.0	1.4	0.9	0.7	3.7	6.9	12.6	1.4	29.4	2.7	0.7	0.6	12.1	1.6	3.0	14.2	6.5	0.8	0.4	8.5	0.9	4.7	4.2	2.7	5.8	1.5	1.6	0.6	1.0	2.1	10.2	0.8	1.0	3.7	1.2	0.2	0.0	0.6	0.0	1.4	4.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	9.1	0.0	0.0	0.0	0.0	0.8	3.2	2.6	0.8	0.0	0.2	0.0	0.0	10.9	0.0	5.2	0.0	0.1	2.8	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.7	0.6	0.0	0.1	2.5	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	9.0	0.0	5.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.1	22.3	0.6	12.7	29.4	2.7	3.0	14.2	4.7	0.2	50.6	0.3	0.0	0.0	0.0	7.3	0.4	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1
ST6GALNAC6	"SIAT7F, ST6GALNACVI"	ENSG00000160408	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6"	Q969X2	9	127885321-127905408	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 94.1;Mucus-secreting cells: 109.4;Paneth cells: 153.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"NK-cells: 12.7;T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.7"									HPA018890	Approved				"Intracellular and membrane"	NA	NA					"HPA018890: AB_1857531"	"unprognostic (2.27e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.67e-2)"	39.3	12.9	45.1	9.7	40.8	7.7	59.6	23.4	37.4	17.2	44.5	8.7	18.6	5.5	14.8	27.3	21.0	31.1	17.8	22.8	38.2	17.0	13.2	18.1	23.5	13.7	18.3	28.3	39.4	19.1	12.7	7.8	10.8	13.6	12.8	72.9	9.6	14.5	22.0	18.9	9.8	9.8	21.9	9.6	18.7	12.1	6.9	15.9	2.3	9.6	9.1	11.2	16.7	29.2	3.3	1.1	2.7	2.8	12.7	16.0	6.5	3.6	3.3	6.5	11.7	52.7	28.5	2.5	9.3	21.4	13.6	11.2	5.5	3.1	3.7	4.1	21.2	9.4	6.2	8.4	6.9	6.3	17.7	4.7	3.9	5.4	5.6	13.8	1.1	6.4	28.9	8.5	9.9	4.4	19.2	13.5	3.7	3.6	4.6	17.5	3.1	2.3	6.1	2.8	3.5	5.9	7.3	8.1	4.5	10.9	0.7	4.1	6.1	6.4	2.6	2.4	4.7	3.1	7.8	8.1	8.1	4.9	8.9	5.1	5.6	3.4	6.9	7.6	1.3	2.8	2.7	0.7	0.1	16.0	1.1	11.7	3.3	10.3	11.5	1.0	2.6	6.5	8.4	0.4	12.7	2.8	1.1	15.3	6.5	45.1	40.8	23.4	37.4	38.2	17.0	18.3	28.3	13.6	15.9	3.0	7.0	15.2	14.5	20.6	18.2	7.0	7.6	4.0	2.3	0.0	5.9	3.2	0.0	0.4	1.7	22.5	94.1	23.3	0.3	6.5	34.0	11.5	6.9	24.2	10.8	23.8	37.0	35.0	6.9	4.7	61.5	5.8	23.6	2.8	109.4	31.6	0.4	153.1	57.3	0.0	6.4	84.1	72.1	1.0	4.3	23.5	3.0	29.8	56.2	15.7
ST8SIA1	"SIAT8, SIAT8A"	ENSG00000111728	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1"	Q92185	12	22063773-22437041	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 43.2;granulocytes: 32.4;Muller glia cells: 41.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;ASC TERT1: 6.0;hTERT-RPE1: 4.2;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026775	Approved					NA	NA					"HPA026775: AB_1857534"	"unprognostic (1.98e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.79e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.16e-2)"	1.7	7.6	7.0	5.3	6.2	2.3	5.9	20.2	13.0	3.5	5.4	2.3	2.3	0.4	4.5	1.4	3.0	2.3	2.4	4.4	7.6	8.5	1.1	0.6	3.8	8.6	7.6	6.5	2.6	1.2	7.2	0.6	0.4	9.4	6.6	3.5	1.5	3.2	4.4	1.0	4.3	2.1	6.3	10.9	2.7	2.1	1.0	4.8	0.2	1.4	0.5	9.2	6.7	3.1	0.3	0.2	1.2	0.2	0.3	3.0	0.6	0.1	0.5	9.1	0.0	1.4	6.0	0.9	0.0	0.0	0.1	0.4	0.3	0.1	1.1	0.0	0.0	0.2	0.4	0.0	0.2	0.6	0.0	0.0	1.1	0.1	0.1	0.0	0.3	0.1	0.5	0.9	0.1	0.9	4.2	0.2	0.1	0.0	0.6	0.2	0.0	1.2	0.3	2.3	3.5	0.0	0.0	0.2	0.2	4.6	0.0	0.1	0.2	0.0	0.1	8.3	0.3	0.7	0.1	0.0	0.7	0.9	0.1	1.4	0.7	0.5	0.7	1.4	0.1	9.0	1.2	0.2	0.2	0.4	0.1	0.9	0.1	2.9	2.3	0.1	0.3	0.4	1.0	0.9	0.3	0.2	0.2	3.0	0.6	7.0	6.2	20.2	13.0	7.6	8.5	7.6	6.5	9.4	4.8	0.0	2.6	0.0	0.4	3.9	7.5	3.1	0.0	8.1	2.3	0.0	43.2	3.0	1.7	0.0	5.3	0.7	0.0	0.0	0.0	10.1	3.0	3.7	32.4	0.0	0.7	4.8	0.0	0.0	0.0	3.0	0.3	0.0	11.8	0.0	0.0	41.7	0.0	0.0	0.0	0.2	2.8	0.0	1.2	3.9	5.5	2.0	3.1	4.3	0.0	0.1
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.8;brain: 36.4"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 6.9;Collecting duct cells: 1.8;Early spermatids: 2.7;Late spermatids: 5.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Region enhanced"	"Detected in many"		"cerebellum: 36.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"WM-115: 52.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"		NA	NA			"Plasma membrane, Midbody"		"HPA043813: AB_2678683, HPA046771: AB_2679798"	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.6	12.8	3.6	0.6	7.8	0.9	0.5	36.4	16.1	0.5	0.5	1.0	0.0	0.7	0.5	0.9	0.4	0.7	0.6	7.2	4.0	1.8	1.5	0.4	0.5	0.5	2.0	6.9	0.7	0.4	4.9	0.7	0.4	4.1	0.6	0.5	0.0	0.4	0.5	8.2	0.7	0.5	0.5	2.5	0.5	0.7	0.9	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.8	0.4	1.5	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.1	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	52.9	1.0	0.4	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.0	0.8	0.3	0.3	1.5	0.5	0.2	0.4	0.1	0.0	3.6	7.8	36.4	16.1	4.0	1.8	2.0	6.9	4.1	0.7	0.0	0.0	0.0	0.0	0.0	1.0	6.9	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33096801	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	6.3	5.4	3.7	6.8	5.2	20.3	6.8	5.3	7.4	4.5	6.9	4.1	7.4	6.4	6.5	12.0	7.0	5.4	9.9	4.4	3.6	3.7	13.9	13.1	9.3	9.6	3.5	3.0	5.7	9.7	12.1	5.2	8.4	4.9	4.6	6.5	9.0	7.7	6.5	3.8	10.3	11.0	4.6	3.8	7.2	6.8	3.2	2.3	2.4	9.5	2.2	7.2	5.3	5.0	0.8	2.2	4.2	5.5	0.1	1.4	0.9	1.3	1.7	1.0	1.6	1.2	1.0	25.5	0.6	0.9	1.5	0.9	2.5	3.5	0.7	1.1	1.6	0.8	1.4	1.6	1.4	2.5	3.8	0.6	3.1	1.7	1.9	0.8	2.6	4.5	1.1	1.2	1.9	1.3	0.7	1.8	1.6	2.3	2.7	1.1	1.2	1.1	1.2	1.0	0.3	1.0	1.3	0.5	1.7	1.4	1.7	0.2	0.6	0.8	2.4	0.6	1.3	1.3	3.8	2.5	2.3	2.9	1.2	2.4	2.2	1.4	0.4	2.9	2.0	1.5	0.0	2.3	0.7	0.4	5.5	1.4	0.8	0.5	0.1	2.2	0.3	0.0	0.0	4.2	0.1	2.3	0.4	0.5	0.9	3.7	5.2	5.3	7.4	3.6	3.7	3.5	3.0	4.9	2.3	0.0	2.2	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	1.3	0.0	0.7	1.2	0.3	0.2	0.0	0.2	0.8	1.6	0.0	0.6	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.4	0.9	0.4	0.3	2.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.6	0.1
